Fewer than 15% of US healthcare organizations have selected a digital pathology vendor, according to a new KLAS report, which also finds higher customer satisfaction with pathology-specific companies.
Read More
Genetic tests accounted for 43% of all Part B lab spending despite representing only 5% of tests performed, according to HHS OIG data.
Read More
Research demonstrates an automated next-generation sequencing workflow designed to reduce hands-on time while delivering next-day CGP results.
Read More
Veracyte will present over 15 studies on its Decipher prostate and bladder cancer tests, including new clinical trial data, at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco.
Read More
Hims & Hers Health is now offering GRAIL’s Galleri multi-cancer blood test through its digital health platform, expanding access to screening for more than 50 cancer types, including those lacking established protocols.
Read More